Titan Medical Inc (TMDIF)

[BIGKAHUNA57]

Reply 120992 Pharmmoney, I don't think MDT shareholders would care if this was $.50 a share knowing that this share price has been artificially suppressed so as to not reflect a more accurate share price commensurate with the value of the existing IP. And the value of that IP's abilities to defend the design(s) of ENOS and any future devices that which it may be incorporated.

Fair market value is all subjective. ISRG has a market cap multiple of 20x actual annual revenue. Takeover targets in biotech are all based on size of potential market, uniqueness of the drug application, ability to enter into alternate-use markets, and how desperate a competitor may be to keep the acquirer from finishing the acquisition.

I don't think this BO will be any different. I'd bet there will be an additional unknown issue/event thrown in for sheer terror, and the possibilities of real life events becoming actually stranger than fiction. I'll be happy to be wrong, and just make it a boring straight-up +$4B BO. (Personally, I think +$4B is very, very cheap. Considering the cost of development time, creativity, ability to navigate existing competitive IP, etc.). And if my math is correct $4B is closer to $32-$34 per share? I like your $40/share better. Someone please check my math and please feel free to correct those figures. As if I need to ask or extend an invitation??? Ha!

This may not be over when we think it's over. Life on the corporate battlefield will remain after this BO.

Good luck to all. Regards,BK.